Previous 10 |
home / stock / bvaxf / bvaxf news
BioVaxys Announces Non-Brokered Private Placement Canada NewsWire VANCOUVER, BC , June 28, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or the "Company") is pleased to announce a non-brokered private placement (the "Privat...
BioVaxys Receives Positive FDA Response For Pre-IND Review For CoviDTH Clinical Development Canada NewsWire VANCOUVER, British Columbia , June 14, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys"), is ple...
BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study Canada NewsWire VANCOUVER, BC and LYON, France , June 1, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (...
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing PR Newswire VANCOUVER, British Columbia , May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA...
Palm Beach, FL – May 20, 2021 – In the race against emerging coronavirus variants, researchers are looking beyond antibodies for clues to lasting protection from COVID-19. Concerns about coronavirus variants that might be partially resistant to antibody defenses have spurred r...
BioVaxys Announces Appointment of Policy Advisor Canada NewsWire VANCOUVER, BC , May 20, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF) ( "BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platfor...
BioVaxys Announces Uplisting To The OCTQB Venture Market Canada NewsWire VANCOUVER, BC , May 19, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and c...
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction Canada NewsWire VANCOUVER, BC , May 3, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (CSE: BIOV.CN) (FRA: 5LB) (OTC: BVAXF ) ( "BioVaxys" or...
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic Commercial trademark application FILED for CoviDTH® diagnostic cancer vaccine platform patent coverage expanded to NOW include over 12 tumor types PR Ne...
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or the " Company ") announ...
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United ...
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...